Physician profile
Brandy Eichelberger
NPI 1750830451
$1,928.34
in general payments reported to CMS, 2019-2025
12 companies · $680 in 2025
The $680 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.71 · 2022: $229 · 2023: $379 · 2024: $629 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.45 |
| Education | $101.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $679.48 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $399.91 | 2024 | Nuplazid |
| Janssen Pharmaceuticals, INC | $252.40 | 2022-2023 | Invega Sustenna |
| Vanda Pharmaceuticals INC. | $124.97 | 2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $123.81 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $117.01 | 2025 | Austedo Xr |
| Alkermes, INC. | $115.04 | 2022 | |
| Pfizer INC. | $53.47 | 2023 | |
| Tris Pharma INC | $22.03 | 2024 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $15.04 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $13.47 | 2022 | |
| Eisai INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Eichelberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.